Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE is a candidate biomarker for lung adenocarcinoma metastasis

Molecular Biology Reports

Volumn 41, Issue 11, 2014, Pages 7507-7523

  Liu, Zan ^a,b   Gao, Yuan ^a,c   Hao, Fengxia ^a   Lou, Xiaomin ^d   Zhang, Xiuwei ^a   Li, Yang ^e   Wu, Di ^e   Xiao, Ting ^f   Yang, Longhai ^f   Li, Qingchang ^a   Qiu, Xueshan ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Medical Device Test Institute   (China)

^c LIAONING UNIVERSITY   (China)

^d Chinese Academy of Sciences   (China)

^e Beijing Protein Innovation   (China)

^f PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

APOE; iTRAQ; Lung adenocarcinoma; Metastasis; Secretomes

Indexed keywords

APOLIPOPROTEIN E; CELL PROTEIN; SECRETOME; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CATION EXCHANGE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER CELL LINE; LUNG METASTASIS; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN TARGETING; RISK ASSESSMENT; ADENOCARCINOMA; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; ION EXCHANGE CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; TISSUE MICROARRAY; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; AREA UNDER CURVE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATOGRAPHY, ION EXCHANGE; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84917673715     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3641-4     Document Type: Article

References (39)

1. Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Gazelle GS, Kelsey DK, LaMonte SJ, Michaelson JS, Oeffinger KC, Shih YC, Sullivan DC, Travis W, Walter L, Wolf AM, Brawley OW, Smith RA (2013) American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63(2):107–117
2. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW (2007) Lung cancer incidence in never smokers. J Clin Oncol 25(5):472–478
3. Folkman J, Shing Y (1992) Angiogenesis J. Biol Chem 267(16):10931–10934
4. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182–1186
5. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257
6. Chih-Ching Wu, Hsu Chia-Wei, Chen Chi-De, Chia-Jung Yu, Chang Kai-Ping, Tai Dar-In, Liu Hao-Ping, Wen-Hui Su, Chang Yu-Sun, Jau-Song Yu (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 9(6):1100–1117
7. Planque C, Kulasingam V, Chris R, Smith Karen Reckamp, Goodglick Lee, Eleftherios P (2009) Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines Mol. Cell Proteomics 8(12):2746–2758
8. Toh SH, Prathipati P, Motakis E, Kwoh CK, Yenamandra SP, Kuznetsov VA (2011) A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma. BMC Genomics 12:Suppl3–S24
9. Tjalsma H, Bolhuis A, Jongbloed JD, Bron S, van Dijl JM (2000) Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol Mol Biol Rev 64(3):515–547
10. Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452(7187):571–579
11. Makridakis M, Vlahou A (2010) Secretome proteomics for discovery of cancer biomarkers. J Proteomics 73(12):2291–2305
12. Volmer MW, Stuhler K, Zapatka M, Schoneck A, Klein-Scory S, Schmiegel W, Meyer HE, Schwarte-Waldhoff I, Volmer MW, Stuhler K, Zapatka M, Schoneck A, Klein-Scory S, Schmiegel W, Meyer HE (2005) Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics 5(10):2587–2601
13. Stastna M, Van Eyk JE (2012) Secreted proteins as a fundamental source for biomarker discovery. Proteomics 12(4–5):722–735
14. Wang Y-C, Chen B-S (2011) A network-based biomarker approach for molecular investigation and diagnosis of lung cancer. BMC Med Genomics 4:2
15. Nibbe RK, Koyuturk M, Chance MR (2010) An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput Biol 6(1):e1000639
16. Vanunu O, Magger O, Ruppin E, Shlomi T, Sharan R (2010) Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol 6(1):e1000641
17. Wang YC, Lan CY, Hsieh WP, Murillo LA, Agabian N, Chen BS (2010) Global screening of potential Candida albicans biofilm-related transcription factors via network comparison. BMC Bioinform 11:53
18. Mahley RW, Rall SC (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507–537
19. Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Arbeeva L, Wu D, Akushevich I, Land KC, Yashin AI (2011) Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell 10(3):533–541
20. Saadat M (2012) Apolipoprotein E (APOE) polymorphisms and susceptibility to breast cancer: a meta-analysis. Cancer Res Treat 44(2):121–126
21. Lou X, Xiao T, Zhao K, Wang H, Zheng H, Lin D, Lu Y, Gao Y, Cheng S, Liu S, Xu N (2007) Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer. J Proteome Res 6(3):1083–1092
22. Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, Hunter CL, Nuwaysir LM, Schaeffer DA (2007) The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 6(9):1638–1655
23. Aretz S, Krohne TU, Kammerer K, Warnken U, Hotz-Wagenblatt A, Bergmann M, Stanzel BV, Holz FG, Schnölzer M, Kopitz J (2013) In-depth mass spectrometric mapping of the human vitreous proteome. Proteome Sci 11(1):22
24. Chen W, Sun CC, Chen S, Meynard D, Babitt JL, Lin HY (2013) A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum. Haematologica 98(2):296–304
25. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Aung PP, Kuraoka K, Nakayama H, Yasui W (2004) Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64(7):2397–2405
26. Xue H, Lu B, Lai M (2008) The cancer secretome: a reservoir of biomarkers. J Transl Med 17(6):52
27. Chen ST, Pan TL, Juan HF, Chen TY, Lin YS, Huang CM (2008) Breast tumor microenvironment: proteomics highlights the treatments targeting secretome. J Proteome Res 7(4):1379–1387
28. Loei H, Tan HT, Lim TK, Lim KH, So JB, Yeoh KG, Chung MC (2012) Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res 11:1759–1772
29. Xue H, Lu B, Zhang J, Wu M, Huang Q, Wu Q, Sheng H, Wu D, Hu J, Lai M (2010) Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 9(1):545–555
30. Mrkonjic M, Chappell E, Pethe VV, Manno M, Daftary D, Greenwood CM, Gallinger S, Zanke BW, Knight JA, Bapat B (2009) Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer. Br J Cancer 100(12):1966–1974
31. Goodison S, Chang M, Dai Y, Urquidi V, Rosser CJ (2012) A multi-analyte assay for the non-invasive detection of bladder cancer. PLoS One 7:e47469
32. Boylan KLM, Andersen JD, Anderson LB, Higgins L, Skubitz AP (2010) Quantitative proteomic analysis by iTRAQ(R) for the identification of candidate biomarkers in ovarian cancer serum. Proteome Sci 8:31
33. Moore LE, Brennan P, Karami S, Menashe I, Berndt SI, Dong LM, Meisner A, Yeager M, Chanock S, Colt J, Schwartz K, Davis F, Zaridze D, Mattveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Holcatova I, Boffetta P, Chow WH, Rosenberg PS, Rothman N (2009) Apolipoprotein E/C1 locus variants modify renal cell carcinoma risk. Cancer Res 69(20):8001–8008
34. Sakashita K, Tanaka F, Zhang X, Mimori K, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M (2008) Clinical significance of ApoE expression in human gastric cancer. Oncol Rep 20(6):1313–1319
35. Ueda K, Saichi N, Takami S, Kang D, Toyama A, Daigo Y, Ishikawa N, Kohno N, Tamura K, Shuin T, Nakayama M, Sato TA, Nakamura Y, Nakagawa H (2011) A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. PLoS One 6(4):e18567
36. Chen J, Wu W, Zhen C, Zhou H, Yang R, Chen L, Hu L (2013) Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. Oncol Lett 6(1):43–48
37. Chen SF, Lin YS, Jao SW, Chang YC, Liu CL, Lin YJ, Nieh S (2013) Pulmonary adenocarcinoma in malignant pleural effusion enriches cancer stem cell properties during metastatic cascade. PLoS One 8(5):e54659
38. Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Li Y, Wen X, Meng QH (2013) The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer. Clin Chim Acta 5(421):230–235
39. Su WP, Chen YT, Lai WW, Lin CC, Yan JJ, Su WC (2011) Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer. Lung Cancer 71(1):28–33